The reason I don't fully buy the holds being lifte
Post# of 154979
(Total Views: 480)
Posted On: 07/31/2023 11:20:31 PM
The reason I don't fully buy the holds being lifted as the end-all-be-all for the rest of CYDY's life is that it doesn't make any business sense for BP to just be waiting for that and then they'll all fight each other for leronlimab. We have all been here long enough remember "Oh when this happens, we're all set!" or "Oh when that happens, CYDY will be a rocket ship!" Don't put all your eggs in the "holds" basket. I HOPE IT HAPPENS and soon, but I don't believe that "all else flows from that."
There is no universal hold on leronlimab. BP could start NASH trials whenever they want. As I have said before, it's like owning a baseball team and wanting to add a certain player, but he won't be available for "X" amount of time. You don't just wait and let the price go up later for him, you get him now and wait it out, knowing how much he will help your team soon.
If BP and CYDY worked together, THAT would bring credibility and the FDA might take CYDY more seriously than they do today, looking at us with the side-eye. The time to buy or partner with CYDY is now, and make it a conditional agreement, conditioned upon the holds being lifted for certain payments to be made, but in the meantime, get going!
There is no universal hold on leronlimab. BP could start NASH trials whenever they want. As I have said before, it's like owning a baseball team and wanting to add a certain player, but he won't be available for "X" amount of time. You don't just wait and let the price go up later for him, you get him now and wait it out, knowing how much he will help your team soon.
If BP and CYDY worked together, THAT would bring credibility and the FDA might take CYDY more seriously than they do today, looking at us with the side-eye. The time to buy or partner with CYDY is now, and make it a conditional agreement, conditioned upon the holds being lifted for certain payments to be made, but in the meantime, get going!
(2)
(0)